Antiviral drug ‘Clevira’ repurposed for treating mild to moderate Covid-19 patients, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Clevira, an antiviral formulation, has received regulatory approval as a supportive treatment for mild to moderate Covid-19 cases, the Chennai-based pharmaceutical company said., Clevira, an antiviral formulation, has received regulatory approval as a supportive treatment for mild to moderate Covid-19 cases, the Chennai-based pharmaceutical company said., , Read More

Leave a Reply

Your email address will not be published.